Replies to post #192334 on Biotech Values

[DewDiligence]

GBIM -45%/PM on insolvency warning:

http://finance.yahoo.com/news/globeimmune-announces-updates-financial-results-103000853.html

At March 31, 2016, GlobeImmune had cash and equivalents of $8.7 million. The Company believes it has sufficient cash to operate the company as a going concern through the middle of 2017 as it continues to evaluate strategic alternatives.

If a strategic alternative is not found in the near future, we could decide to wind down the operations of the Company which will consume cash faster than currently planned as a going concern.